Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
ABVC BioPharma, Inc. - Common Stock
(NQ:
ABVC
)
2.100
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about ABVC BioPharma, Inc. - Common Stock
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
ABVC BioPharma Provides ADHD Phase II Part 2 Clinical Study Update and Announces UCSF Institutional Review Board Approval
September 22, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
ABVC Biopharma Announces Letter to Shareholders
September 13, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
ABVC BioPharma Selects Additional Vitargus Phase II Study Site
September 09, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
August 23, 2022
Gainers
Via
Benzinga
Why Nikola Dropped Over 9%; Here Are 66 Biggest Movers From Yesterday
↗
August 31, 2022
Gainers Mobile Global Esports Inc. (NASDAQ: MGAM) shares surged 103.9% to settle at $5.30 on Tuesday. Shares are in low-float territory; the issue has about 15 million shares in its float.
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
August 22, 2022
Gainers ABVC BioPharma (NASDAQ:ABVC) shares increased by 12.8% to $0.97 during Monday's after-market session. The company's market cap stands at $31.6 million.
Via
Benzinga
ABVC Provides Oncology Pipeline Updates
August 22, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
ABVC BioPharma Provides Vitargus Update
August 18, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
August 18, 2022
Via
Benzinga
ABVC BioPharma Reports Second Quarter 2022 Financial and Operational Results
August 15, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Stocks That Hit 52-Week Lows On Wednesday
↗
August 10, 2022
During Wednesday, 52 stocks hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
↗
August 02, 2022
Tuesday's session saw 63 companies set new 52-week lows.
Via
Benzinga
ABVC BioPharma Provides Vitargus Update
August 02, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
July 19, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
↗
August 01, 2022
On Monday, 92 companies set new 52-week lows.
Via
Benzinga
ABVC Notes New Report That Estimates Global Retinal Surgical Instruments Market to Grow to $2.46 Billion by 2028
July 18, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Stocks That Hit 52-Week Lows On Thursday
↗
July 28, 2022
On Thursday, 108 companies set new 52-week lows.
Via
Benzinga
ABVC Biopharma Provides Enrolment Update In Mid-Stage Attention Deficit Disorder Study
↗
July 13, 2022
ABVC Biopharma (NASDAQ: ABVC) provided an update on the enrollment progress in the Phase II Part II clinical study of its ADHD candidate (ABV-1505).
Via
Benzinga
ABVC BioPharma Provides ADHD Phase II Part 2 Clinical Update
July 13, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
This Healthcare Stock is Down By More Than 50%: Here's 25 Stocks Moving Premarket
↗
July 13, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
July 12, 2022
Gainers Guardant Health (NASDAQ:GH) stock rose 14.8% to $55.23 during Tuesday's after-market session. The market value of their outstanding shares is at $5.6 billion.
Via
Benzinga
Zacks Places Share Value of ABVC BioPharma at $9.50
July 06, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
ABVC BioPharma Provides Vitargus Update
June 30, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Stocks That Hit 52-Week Lows On Friday
↗
June 24, 2022
On Friday, 61 companies hit new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
June 22, 2022
Gainers ABVC BioPharma (NASDAQ:ABVC) shares increased by 12.3% to $1.03 during Wednesday's after-market session. The company's market cap stands at $33.2 million.
Via
Benzinga
ABVC BioPharma Expands Co-Development Partnership With Rgene Corporation
June 21, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
ABVC BioPharma Submitted Vitargus Phase II Study Plan to Australia HREC
June 16, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
June 15, 2022
Via
Benzinga
93 Biggest Movers From Yesterday
↗
June 14, 2022
Gainers Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares surged 126% to close at $14.96 on Monday after the company announced initial data from the pivotal FIREFLY-1 trial of tovorafenib in...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
June 13, 2022
Gainers
Via
Benzinga
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
